Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subconjunctival mesenchymal stem cell injection in limbal stem cell deficiency
TCTR20251209011Phase 1Recruiting
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Jan 2026
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 1, single-arm trial of mesenchymal stem cell therapy (Hexun Biosciences) in limbal stem cell deficiency (LSCD), sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Started Jan 2026; status: recruiting.
02
Drugs
mesenchymal stem cell therapy (Hexun Biosciences)
03
Conditions
limbal stem cell deficiency (LSCD)
Beyond the preview
Go deeper on TCTR20251209011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251209011.